Assessment of anti-mutagenic effects of stobadine dihydro-chloride on MNNG-induced mutations in Chinese hamster cells V79

Mutagenicity of N-methyl-n'-nitro-N-nitrosoguanidine (MNNG) and anti-mutagenic effect of antioxidant stobadine (STB) were investigated by so called HGPRT/V79 system. Cells were treated by STB before, during and after MNNG-treatment. Our results showed that the highest anti-mutagenic effect of STB was observed if the drug was given as a pretreatment before exposure of cells to MNNG. This effect was not concentration dependent within the framework of 1.5 - 9 mmol. All other combinations of MNNG- and STB-treatment led to the weaker but statistically significant decrease of 6-TGr mutations. Inhibition of proteosynthesis induced by methylxanthine pentoxifylline in the time of pre-MNNG-treatment removed completely anti-mutagenic effects of STB. In addition of mutagenicity assays, cytotoxicity of STB and combined effects of MNNG and STB were studied. Trypan blue exclusion and growth activity of influenced cells showed that application of STB (1.5 mmol) before or after MNNG (0.5 μg/cm3) treatment had a similar toxic effects as MNNG alone. Application of STB during MNNG-treatment or pretreatment of cells with STB followed by combined treatment of cells by STB + MNNG statistically significantly decreased viability of cells. There are probably no relationship between the anti-mutagenic and the toxic effects of combined influence of STB and MNNG on V79 cells. (author)